The findings from the Burton, Nemazee and Schief labs could provide key information for the development of an effective AIDS vaccine.
The approach from the Griffin lab could promote the development of new bone-forming cells.
The findings from the Ollmann Saphire lab add to the “blueprint” for developing effective treatments.
Research from the Subramaniam lab could help treat the neurological condition’s pathology and motor symptoms.
Research from the Chun lab and colleagues reveals a surprising link to marijuana receptor system.
Scientists in the Cravatt lab have devised a powerful set of chemical methods to study important molecular interactions that could become the basis of new drugs.
The grant, led by Patrick Griffin, chair of the Department of Molecular Therapeutics, will fund deep dissection of the molecular mechanism of a new class of compounds developed at TSRI.